You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Type 2 Inflammation

ADVENT Forum 2022 | Multidisciplinary Management of Patients with Type 2 Inflammatory Diseases

Prof. Arjan Bredenoord and Drs. Bob Geng, Lawrence Eichenfield, Michael Wechsler, and Michael Blaiss review patient burden associated with type 2 inflammatory diseases and the need for multidisciplinary management

Bob Geng
Lawrence F. Eichenfield
Michael  Wechsler
MD
Bob Geng +4 more

Learning objectives

  • Describe the evolution of type 2 inflammation from protection to pathology
  • Examine the shared and distinct roles of type 2 inflammatory mediators in the pathology of diseases with underlying type 2 inflammation
  • Highlight the importance of a multidisciplinary approach and shared decision-making in the patient-centered care in type 2 inflammatory diseases
  • Evaluate the latest clinical data for biologics in atopic dermatitis and in asthma in pediatric patients

Description

Arjan Bredenoord, MD, PhD; Bob Geng, MD; Lawrence Eichenfield, MD; Michael Wechsler, MD; and Michael Blaiss, MD, review patient burden associated with type 2 inflammatory diseases and the need for multidisciplinary management and shared-decision making  to improve outcomes and overall patient experience.

MAT-GLB-2205551 v2.0 01/2023

About these experts

Related resources